In the present study, different stages of transitional cell carcinoma of the bladder were analyzed by fluorescent in situ hybridization, using probes specific for pericentromeric classical satellite. Seventy primary tumors were evaluated for chromosomes 1, 7, 9, 17, and ploidy by flow cytometry. The results were correlated, after a mean follow-up period, with ploidy, histopathological characteristics, recurrence, and progression. Firstly, our data demonstrated that the sensitivity of fluorescence in situ hybridization in detecting quantitative DNA. aberrations exceeds that of flow cytometry. The frequency of chromosome I and 9 aberrations was not significantly different in diploid and aneuploid tumors of different stage and grade. In contra...
Objective: To understand developmental characteristics of urinary bladder carcinomas (UBC) by evalua...
<p>Fluorescence in situ hybridization (FISH) assay was used to detect tumor cells in the urine sedim...
During the past decades, the complexity of the bladder cancer genome has become evident. Early cytog...
We evaluated the genetic changes in bladder cancer biopsy by fluorescence in situ hybridization (FIS...
Objective To determine if changes in chromosome 7 and 17 copy number can be used to predict recurren...
A systematic analysis of both tumors and the surrounding urothelium to help identify what lies behin...
A multiprobe interphase fluorescence in situ hybridization (I-FISH) approach has become a useful a...
Transitional cell carcinoma (TCC) provides a unique model of cancer recurrence and progression. Sequ...
To define the genetic changes of flat urothelial lesions, carcinoma in situ (CIS) and moderate dyspl...
Detection of molecular alterations is of potential significance for diagnosis and prognosis in bladd...
Bladder carcinoma with transitional cells is the most frequent neoplasia in the urinary system, but ...
Bladder cancer is the second common malignant urological neoplasia. Most of the tumors are superfici...
Investigation of transitional cell carcinoma of the urinary bladder (TCC) patients classified by rec...
Bladder cancer is a common neoplasm worldwide, consisting mainly of transitional cell carcinomas, wh...
Aim: To evaluate the potential contribution of a fluorescent in situ hybridization (FISH) as prognos...
Objective: To understand developmental characteristics of urinary bladder carcinomas (UBC) by evalua...
<p>Fluorescence in situ hybridization (FISH) assay was used to detect tumor cells in the urine sedim...
During the past decades, the complexity of the bladder cancer genome has become evident. Early cytog...
We evaluated the genetic changes in bladder cancer biopsy by fluorescence in situ hybridization (FIS...
Objective To determine if changes in chromosome 7 and 17 copy number can be used to predict recurren...
A systematic analysis of both tumors and the surrounding urothelium to help identify what lies behin...
A multiprobe interphase fluorescence in situ hybridization (I-FISH) approach has become a useful a...
Transitional cell carcinoma (TCC) provides a unique model of cancer recurrence and progression. Sequ...
To define the genetic changes of flat urothelial lesions, carcinoma in situ (CIS) and moderate dyspl...
Detection of molecular alterations is of potential significance for diagnosis and prognosis in bladd...
Bladder carcinoma with transitional cells is the most frequent neoplasia in the urinary system, but ...
Bladder cancer is the second common malignant urological neoplasia. Most of the tumors are superfici...
Investigation of transitional cell carcinoma of the urinary bladder (TCC) patients classified by rec...
Bladder cancer is a common neoplasm worldwide, consisting mainly of transitional cell carcinomas, wh...
Aim: To evaluate the potential contribution of a fluorescent in situ hybridization (FISH) as prognos...
Objective: To understand developmental characteristics of urinary bladder carcinomas (UBC) by evalua...
<p>Fluorescence in situ hybridization (FISH) assay was used to detect tumor cells in the urine sedim...
During the past decades, the complexity of the bladder cancer genome has become evident. Early cytog...